Breadcrumb Navigation

8th International Congress of the Swiss Society for Pulmonary Hypertension

It is our privilege to invite and welcome you to the 8th International Congress of the Swiss Society of Pulmonary Hypertension 2022.

Maskenpflicht
In den öffentlich zugänglichen Bereichen des USZ gilt eine Maskenpflicht.

Standort

Universitätsspital Zürich
Grosser Hörsaal NORD1
Frauenklinikstr. 10 / D304
8091 Zürich

17.03.2022 12.30 - 18.45 Uhr
18.03.2022 8.55 - 15.40 Uhr
Sign up here

Dear colleagues,

The event will take place at the University Hospital Zurich from March 17 – 18, 2022. The scientific program will provide state-of-the-art sessions given by experts as well as a platform for the presentation of original research in the field of pulmonary hypertension. In addition, there will be an award ceremony, you will have the possibility to attend satellite symposia and to visit the industrial exhibition.

The main topics of the scientific program revolve around:

  • Definition of PH
  • Chronic thromboembolic PH
  • PH during a lifetime
  • Special monitoring situations

You will have great opportunities to meet colleagues from the field and to get in contact with renowned experts from Switzerland, Belgium, Austria, Great Britain, France and Germany.

Save the date for the 8th International Congress of the Swiss Society for Pulmonary Hypertension and be part of it. We are pleased to welcome both the medical and nursing communities.

For the scientific committee

Prof. Markus Schwerzmann, MD, Bern
President of the SSPH

Prof. Ulrich Silvia, MD, Zurich
Lead Scientific Committee

Margret Riboch, Ticino
Vice President of the SSPH/Lead PH Nurses

Program, Thursday, March 17, 2022

12.30 – 12.35
Opening Comments
Markus Schwerzmann, Berne

12.35 – 14.30
Session 1: Definition of PH
Chairs: Markus Schwerzmann, Berne | Andrea Azzola, Lucerne

12.35 – 13.05
How Should we (Re)define PH?
Frédéric Lador, Geneva

13.05 – 13.40
New Definition of PH Under Stress – Excercice & Hypoxia
Silvia Ulrich, Zurich

13.40 – 14.05
Implications of the Proposed New Definition on PH in Left Heart Disease
Jean-Luc Vachiery, Brussels, BE

14.05 – 14.30
Implications of the Proposed New Definition on PH in Lung Disease
Horst Olschewski, Graz, AT

14.30 – 15.00
Coffe Break | Poster Viewing (First Author on Site)

15.00 – 15.45
Satellite Symposium organized by Janssen-Cilag AG
PHocus on PAH: New Data – Impact on the Management of this Rare Disease

Chairs: Silvia Ulrich, Zurich; Markus Schwerzmann, Berne

  • 15.00 – 15.20
    Update on PH (Studies)
  • 15.20 – 15.45
    Discussion of the Data and Its Use in Practice
    Speaker tba; Silvia Ulrich, Zurich; Markus Schwerzmann, Berne

15.45 – 17.25
Session 2: Chronic Thromboembolic PH
Chairs: Isabelle Schmidt-Opitz, Zurich | Anne-Lise Hachulla, Geneva

  • 15.45 – 16.10
    From Acute PE to CTEPH: Who Needs Screening?
    John-David Aubert, Lausanne
  • 16.10 – 16.35
    Novel Insight From the Pathogenesis of CTEPH
    Pepke-Zaba, Cambridge, UK
  • 16.35 – 17.00
    Multimodal Invasive Therapy in CTEPH
    Philippe Brenot, Paris, FR
  • 17.00 – 17.25
    Anticoagulation in CTEPH
    Helia Robert Ebadi, Geneva

17.25 – 18.00
Apéro

18.00 – 18.45
General Assembly

Program, Friday, March 18, 2022

8.55 – 9.00
Welcome and Opening Comments
Silvia Ulrich, Zurich

9.00 – 10.20
Session 3: PH During Lifetime
Chairs: Margret Riboch, Locarno | Jean-Marc Fellrath, Neuchâtel

  • 9.00 – 9.20
    Adolescence – Young Patients with PH- Transition
    Maurice Beghetti, Geneva
  • 9.20 – 9.40
    Living with PAH in Adulthood- a Special Challenge for SSc-PAH
    Robin Condliffe, Sheffield, UK
  • 9.40 – 10.00
    Elderly Patients with PH- Comorbidities and Other Special Aspects of Care
    Ekkehard Grünig, Heidelberg, DE
  • 10.00 – 10.20
    Palliative Care – Principals of Pallative Care in PH
    Wendy Gin-Sing, London, UK

10.20 – 10.50
Coffee Break | Poster Viewing (First Author on Site)

10.50 – 12.30
Session 4: Special Monitoring Situations
Chairs: Susanne Pohle, St.Gallen | Mona Lichtblau, Zurich

  • 10.50 – 11.15
    Novel Imaging Modalities for the Pulmonary Vasculature: The Radiologists View
    Jens Vogel-Claussen, Hannover, DE
  • 11.15 – 11.40
    Non Invasive Assessments and Early Detection – Echo in Clinics and Reasearch
    Patrick Yerly, Lausanne
  • 11.40 – 12.05
    Complex Assessment of the Right Heart- Pulmonary Vascular Unit – The Value of Single Beat Pressure- Volume Loops
    Khodr Tello, Giessen, DE
  • 12.05 – 12.30
    Perioperative Threat in PH – the Anaesthetist State of the Art
    Rolf Schüpbach, Zurich

12.30 – 13.30
Lunch | Poster Viewing

13.30 – 14.15
Satellite Symposium organized by Gebro Pharma AG
Interdisciplinary Treatment of PAH

Chair: Silvia Ulrich, Zurich

  • 13.30-13.35
    Welcome
    Silvia Ulrich, Zurich
  • 13.35 – 13.50
    Interdisciplinary Treatment of P(A)H Patients – How the Collaboration of Pneumologists and Cardiologists Could Look Like
    Sabina Guler, Berne; Markus Schwerzmann, Berne
  • 13.50 – 13.55
    Discussion
    Silvia Ulrich, Zurich
  • 13.55 – 14.10
    Triple Therapy for PAH in Real Life
    Ekkehard Grünig, Heidelberg, DE
  • 14.10 – 14.15
    Discussion and Closure
    Silvia Ulrich, Zurich

14.15 – 15.25
Session 5: Up-to Date Therapy in PAH
Chairs: Simone Stickel, Zurich | Michael Tamm, Basel

  • 14.15 – 14.40
    Risk Stratification in PH – Pitfalls and Recommendation From Registries
    Marion Delcroix, Leuven, BE
  • 14.40 – 15.05
    Novel Pathogenetic Insights in PAH – Upcoming Novel Therapies from the Bench to Bedside
    Marc Humbert, Paris, FR
  • 15.05 – 15.25
    Current Medical Therapy of PAH: State-of the Art
    Oliver Sitbon, Paris, FR

15.25 – 15.40
Award Ceremony and Closing Remarks
Chairs: Silvia Ulrich, Zurich | Markus Schwerzmann, Berne

Verantwortlicher Fachbereich

Klinik für Pneumologie